AraGen Biotechnology is a Jordanian start-up specialized in medical diagnostics. Having recognized that innovation is the only way to prosper in this high-technology sector, AraGen dedicated its resources to addressing unmet public health needs; particularly, in the developing world. Research fructified in over 200 point-of-care and professional testing products based entirely on in-house patented technologies. The innovative products characterized by enhanced sensitivity, stability, validity, mobility, coverage and user-friendliness are offered at low prices attainable even in developing countries. In 2009, AraGen¿s patents were independently valuated at $22.05 Million USD outlining the value of the Company amidst a partial divestment transaction involving 33% of its shares. The portrayal of AraGen is inspiring to entrepreneurs worldwide. Its model can be adopted by small and medium enterprises (SME); allocating resources to constructive research and protecting the resulting innovations through the patent system in order to gain the leveraging power of intellectual property assets. It also serves as a scientific reference for the researchers in the field of medical diagnostics.
Prenumerera på vårt nyhetsbrev för att få fantastiska erbjudanden och inspiration för din nästa läsning.
Genom att registrera dig accepterar du vår personuppgiftspolicy.
